Skip to main content

Animations

MJFF Publications

3691 - 3700 of 9038 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2025
  • 2021
  • 2021
  • 2021
  • 2020
  • 2020
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-025-03834-0
    Citation Count: 93
  • Summary Details
    OPEN
    Title: POLCAM: instant molecular orientation microscopy for the life sciences
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02382-8
    Citation Count: 20
  • Summary Details
    OPEN
    Title: An axonal brake on striatal dopamine output by cholinergic interneurons
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-025-01906-5
    Citation Count: 18
  • Summary Details
    OPEN
    Title: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Contribution of rare variant associations to neurodegenerative disease presentation
    Journal Name: npj Genomic Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41525-021-00243-3
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202013257
    Citation Count: 167
  • Summary Details
    OPEN
    Title: Variational Autoencoder Modular Bayesian Networks for Simulation of Heterogeneous Clinical Study Data
    Journal Name: Frontiers in Big Data
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fdata.2020.00016
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Pyk2 overexpression in postsynaptic neurons blocks amyloid β1–42-induced synaptotoxicity in microfluidic co-cultures
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaa139
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Cognitive impairment in Parkinson's disease is associated with Default Mode Network subsystem connectivity and cerebrospinal fluid Aβ
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.002
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa401
    Citation Count: 55
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.